Rooibos for Blood Sugar Regulation

Research suggests that rooibos may support blood sugar regulation through several molecular mechanisms, with studies pointing to improvements in insulin signaling, glucose uptake, and glucose metabolism. The available evidence comes entirely from preclinical sources — specifically cell culture experiments and animal models, including diabetic and insulin-resistant rats — and consistently trends in a supportive direction, with rooibos extracts and isolated rooibos compounds shown to activate proteins involved in glucose transport such as GLUT4, AKT, and AMPK, while also improving insulin signaling pathways in tissues affected by diabetes. One study identified phenylpyruvic acid-2-O-glucoside, a compound specific to fermented rooibos, as a potentially novel antidiabetic agent that appeared to work through liver-based gene regulation. However, the absence of human clinical trials means these findings cannot yet be translated into conclusions about how rooibos consumption affects blood sugar in people, and the results should be understood as early-stage mechanistic evidence rather than established clinical benefit.